MedPath

nu-derm system normal-dry

OBAGI NU-DERM SYSTEM

Approved
Approval ID

7548658a-5371-4aed-baf8-e5dc54262223

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2023

Manufacturers
FDA

OBAGI COSMECEUTICAL LLC

DUNS: 790553353

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydroquinone, Octisalate and Zinc Oxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62032-529
Product Classification
G
Generic Name
Hydroquinone, Octisalate and Zinc Oxide
Product Specifications
Effective DateJanuary 19, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

nu-derm system normal-dry - FDA Drug Approval Details